
Standard Chemical & Pharmaceutical Co., Ltd. — Investor Relations & Filings
Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 代子公司「江蘇生達生技醫藥有限公司」公告資金貸與 超限改善計畫執行情形 | 2026-05-12 | Chinese | |
| 公告董事會通過115年第一季合併財務報告 | 2026-05-12 | Chinese | |
| 公告本公司股東會決議通過解除董事之競業禁止 | 2026-05-12 | Chinese | |
| 公告本公司115年度股東常會重要決議事項 | 2026-05-12 | Chinese | |
| 公告本公司民國115年第一季財務報告 董事會預計召開日期為115年05月12日 | 2026-05-04 | Chinese | |
| 114年第4季財務報告書 — 202504_1720_AIC.pdf | 2026-04-24 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46246657 | 代子公司「江蘇生達生技醫藥有限公司」公告資金貸與 超限改善計畫執行情形 | 2026-05-12 | Chinese | ||
| 46232147 | 公告董事會通過115年第一季合併財務報告 | 2026-05-12 | Chinese | ||
| 46216867 | 公告本公司股東會決議通過解除董事之競業禁止 | 2026-05-12 | Chinese | ||
| 46205011 | 公告本公司115年度股東常會重要決議事項 | 2026-05-12 | Chinese | ||
| 40861979 | 公告本公司民國115年第一季財務報告 董事會預計召開日期為115年05月12日 | 2026-05-04 | Chinese | ||
| 35967131 | 114年第4季財務報告書 — 202504_1720_AIC.pdf | 2026-04-24 | English | ||
| 35967107 | 114年第4季財務報告書 — 202504_1720_AIA.pdf | 2026-04-24 | English | ||
| 35967070 | 114年第4季財務報告書 — 202501_1720_AIA.pdf | 2026-04-24 | English | ||
| 35967026 | 114年第4季財務報告書 — 202501_1720_AI1.pdf | 2026-04-24 | Chinese | ||
| 35703368 | 115年年報及股東會資料 — 2026_1720_20260512F17.pdf | 2026-04-23 | Chinese | ||
| 35703340 | 115年年報及股東會資料 — 2025_1720_20260512FE4.pdf | 2026-04-23 | English | ||
| 35703283 | 115年年報及股東會資料 — 2025_1720_20260512F04.pdf | 2026-04-23 | Chinese | ||
| 33985153 | 115年年報及股東會資料 — 2026_1720_20260512FE2.pdf | 2026-04-10 | English | ||
| 33985145 | 115年年報及股東會資料 — 2026_1720_20260512F01.pdf | 2026-04-10 | Chinese | ||
| 33977981 | 115年年報及股東會資料 — 2026_1720_20260512F02.pdf | 2026-04-10 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Standard Chemical & Pharmaceutical Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51900/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51900 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51900 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51900 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51900}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Standard Chemical & Pharmaceutical Co., Ltd. (id: 51900)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.